Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

26 Apr 2013

Abstract excerpt

Primary therapy for Hodgkin lymphoma (HL) is curative in ˜ 85% of patients [1]. Randomized phase III and single arm phase II trials have established high dose chemotherapy and autologous hematopoie...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Lung Cancer Treatments and Mutations
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23617324
DOI: 10.3109/10428194.2013.798868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplantPMID 23617324Read ↗

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplantSemantic proximity Read ↗

From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.Semantic proximity Read ↗

Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialSemantic proximity Read ↗

Non-Hodgkin lymphoma: diagnosis and treatment.Semantic proximity Read ↗

Advances in biology, diagnostics, and treatment of Hodgkin's disease.Semantic proximity Read ↗

What is the role of autologous transplant for lymphoma in the current era?Semantic proximity Read ↗

Your chemo is no good here: management of high-risk MCL.Semantic proximity Read ↗

The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy<sup/>.Semantic proximity Read ↗

Ofatumumab as Part of Reduced Intensity Conditioning in High Risk B-cell Lymphoma Patients: Final Long-term Analysis From a Prospective Multicenter Phase-ii TrialSemantic proximity Read ↗

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphomaSemantic proximity Read ↗

Hematopoietic Cell Transplantation for LymphomasSemantic proximity Read ↗

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow TransplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.